LONG^®R³IGF-I

A highly potent and effective cGMP alternative to recombinant insulin for cell culture applications. LONG^®R³IGF-I has been specifically engineered for serum-free cell culture supplementation, to improve process efficiency without compromising on safety or compliance.

Used in the manufacture of several FDA, EMEA and Japanese FDA products with more in late-phase clinical trials.

Key benefits

• Increased cell density, higher viability and extended culture duration
• Available as lyophilized powder or ready-to-use liquid formulation
• Animal-free and regulatory-compliant
• Consistent quality and performance
• Secure supply.

Application areas

• Industrial scale biomanufacturing.